Literature DB >> 10364770

Out-of-hospital coagulation monitoring and management.

J E Ansell1.   

Abstract

Mesh:

Substances:

Year:  1999        PMID: 10364770     DOI: 10.1023/a:1008893706046

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  41 in total

1.  Patient self-management of oral anticoagulation guided by capillary (fingerstick) whole blood prothrombin times.

Authors:  J Ansell; A Holden; N Knapic
Journal:  Arch Intern Med       Date:  1989-11

Review 2.  Evolving models of warfarin management: anticoagulation clinics, patient self-monitoring, and patient self-management.

Authors:  J E Ansell; R Hughes
Journal:  Am Heart J       Date:  1996-11       Impact factor: 4.749

3.  Bleeding complications of oral anticoagulant treatment: an inception-cohort, prospective collaborative study (ISCOAT). Italian Study on Complications of Oral Anticoagulant Therapy.

Authors:  G Palareti; N Leali; S Coccheri; M Poggi; C Manotti; A D'Angelo; V Pengo; N Erba; M Moia; N Ciavarella; G Devoto; M Berrettini; S Musolesi
Journal:  Lancet       Date:  1996-08-17       Impact factor: 79.321

4.  Home prothrombin time monitoring after the initiation of warfarin therapy. A randomized, prospective study.

Authors:  R H White; S A McCurdy; H von Marensdorff; D E Woodruff; L Leftgoff
Journal:  Ann Intern Med       Date:  1989-11-01       Impact factor: 25.391

5.  Bleeding complications to oral anticoagulant therapy: multivariate analysis of 1010 treatment years in 551 outpatients.

Authors:  J Launbjerg; H Egeblad; J Heaf; N H Nielsen; A M Fugleholm; K Ladefoged
Journal:  J Intern Med       Date:  1991-04       Impact factor: 8.989

6.  Advances in the Monitoring of Oral Anticoagulation: Point-of-Care Testing, Patient Self-Monitoring, and Patient Self-Management.

Authors: 
Journal:  J Thromb Thrombolysis       Date:  1996       Impact factor: 2.300

7.  Risk factors for intracranial hemorrhage in outpatients taking warfarin.

Authors:  E M Hylek; D E Singer
Journal:  Ann Intern Med       Date:  1994-06-01       Impact factor: 25.391

8.  Prothrombin time ratio and other factors associated with bleeding in patients treated with warfarin.

Authors:  D B Petitti; B L Strom; K L Melmon
Journal:  J Clin Epidemiol       Date:  1989       Impact factor: 6.437

9.  Bleeding during antithrombotic therapy in patients with atrial fibrillation. The Stroke Prevention in Atrial Fibrillation Investigators.

Authors: 
Journal:  Arch Intern Med       Date:  1996-02-26

10.  Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota.

Authors:  M J Gitter; T M Jaeger; T M Petterson; B J Gersh; M D Silverstein
Journal:  Mayo Clin Proc       Date:  1995-08       Impact factor: 7.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.